Date: 2016-05-05
Type of information: Nomination
Compound:
Company: Nuevolution (Denmark)
Therapeutic area: Inflammatory diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On November 18, 2015, Nuevolution announced that Dr. Mark Genovese has joined as Scientific Advisor. Dr. Genovese brings a vast knowledge and expertise within the field of inflammatory diseases to Nuevolution as well as a profound understanding of pre-clinical and clinical research, supporting the commercial value of Nuevolution’s program pipeline. He serves as a Professor of Medicine and is Co-Chief of the Division of Immunology and Rheumatology at Stanford University Medical Center. He established a clinical research program at Stanford University that is focused on bench-to-bedside translational medicine in autoimmune diseases and has designed and participated in many trials investigating novel therapies and therapeutic strategies for the treatment of autoimmune disease and arthritis.
Financial terms:
Latest news:
